Sitagliptin inhibit human lymphocytes proliferation and Th1/Th17 differentiation in vitro-Reference-Cited by-同舟云学术

Sitagliptin inhibit human lymphocytes proliferation and Th1/Th17 differentiation in vitro

Published:2017-03 Issue: Volume:100 Page:17-24
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Pinheiro Marcelo Maia,Stoppa Caroline Lais,Valduga Claudete Justina,Okuyama Cristina Eunice,Gorjão Renata,Pereira Regina Mara Silva,Diniz Susana Nogueira

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Anhanguera University of São Paulo

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference42 articles.

1. Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes;Ahrén;Diabetes Care,2002

2. Novel aspects of cellular action of dipeptidyl peptidase IV/CD26;Ansorge;Biol. Chem.,2011

3. Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated beta-cell death;Arif;Diabetes,2011

4. Dipeptidyl peptidase IV (DP IV/CD26) mRNA expression in PWM-stimulated T-cells is suppressed by specific DP IV inhibition, an effect mediated by TGF-β1;Arndt;Biochem. Biophys. Res. Commun.,2000

5. Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26);Bengsch;J. Immunol.,2012

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of Diptptidyl peptidase-4 inhibitors combined with insulin in patients with autoimmune diabetes: A updated meta-analysis;Endocrine and Metabolic Science;2024-06

2. Comment on Narsale et al. Th2 cell clonal expansion at diagnosis in human type 1 diabetes. Clin Immunol. 2023 Oct 29;Clinical Immunology;2024-01

3. Sitagliptin Induces Tolerogenic Human Dendritic Cells;International Journal of Molecular Sciences;2023-11-27

4. Immunometabolic biomarkers for partial remission in type 1 diabetes mellitus;Trends in Endocrinology & Metabolism;2023-11

5. Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention;Frontiers in Immunology;2023-10-05